Evidence map›Paper›PMID 37489008›Full record

ArticleActa biochimica et biophysica Sinica2023

Saikosaponin D reverses epinephrine- and norepinephrine-induced gemcitabine resistance in intrahepatic cholangiocarcinoma by downregulating ADRB2/glycolysis signaling.

Hui He, Jiaqi Guo, Yunxiang Hu, Han Zhang, Xinyang Li, Jian Zhang, Shi Jin

Open access · diamondAbstract read
In one paragraph

Article in Acta biochimica et biophysica Sinica, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers.

0numbers the graph read from it
0cells of the map it votes in
20citing papers in PubMed
4.0field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

20 citing papers in PubMed, 18 citations in OpenAlex.

  1. Review
  2. Article
  3. Review
  4. Review
  5. Review
  6. Review
  7. Mechanisms of Baishao () and Gancao () on major depressive disorder: network pharmacology and o validation.Journal of traditional Chinese medicine = Chung i tsa chih ying wen pan · 2025
    Article
  8. Article
  9. Review
  10. Review
  11. Review
  12. Article
  13. Article
  14. Review
  15. Article
  16. Review
  17. Review
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 1 institution in 1 country.

Hui HeDepartment of Laparoscopic Surgery, the First Affiliated Hospital of Dalian Medical University, Dalian 116000, China.
Jiaqi GuoDepartment of Laparoscopic Surgery, the First Affiliated Hospital of Dalian Medical University, Dalian 116000, China.
Yunxiang HuDepartment of Laparoscopic Surgery, the First Affiliated Hospital of Dalian Medical University, Dalian 116000, China.
Han ZhangDepartment of Laparoscopic Surgery, the First Affiliated Hospital of Dalian Medical University, Dalian 116000, China.
Xinyang LiDepartment of Laparoscopic Surgery, the First Affiliated Hospital of Dalian Medical University, Dalian 116000, China.
Jian ZhangDepartment of Interventional Therapy, the First Affiliated Hospital of Dalian Medical University, Dalian 116000, China.
Shi JinDepartment of Laparoscopic Surgery, the First Affiliated Hospital of Dalian Medical University, Dalian 116000, China.
Dalian Medical University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Intrahepatic cholangiocarcinoma (iCCA) is a highly fatal malignancy with rapidly increasing incidence and mortality worldwide. Currently, gemcitabine-based systemic chemotherapy is the main clinical therapeutic regimen; however, its efficacy is poor, and its mechanism has not been elucidated. In this study, we use a Seahorse Extracellular Flux analyser to measure glycolysis capacity (extracellular acidification rate, ECAR) and oxygen consumption rate (OCR). The glucose uptake or lactic acid content is detected, and the effects of saikosaponin D, an active compound derived from

Indexed as

Bile Duct NeoplasmsCholangiocarcinomaBile Ducts, IntrahepaticEpinephrineGemcitabineGlycolysisHumansNorepinephrineOleanolic AcidReceptors, Adrenergic, beta-2SaponinsADRB2 protein, humanEpinephrineGemcitabineNorepinephrineOleanolic AcidReceptors, Adrenergic, beta-2saikosaponin DSaponinsADRB2gemcitabine resistanceglycolysisintrahepatic cholangiocarcinomasaikosaponin D

Identifiers

PMID37489008
PMCPMC10520481
OpenAlexW4323354301

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.